Loading
Tenon Medical, Inc. Stock: price and insider trades · United States
1 insider bought €430k of shares over the last 90 days, the latest by HRT FINANCIAL LP, filed 11 Sept 2026.
Tenon Medical, Inc.: what insiders have been doing
Tenon Medical, Inc. is a Health Care company. Its directors and officers file their transactions with SEC (Form 4). The last twelve months, up to 23 October 2026, brought 54 filings signed by 11 insiders.
On the market, 4 insiders bought (12 purchases totalling €430k) while 1 insider sold (9 sales totalling €521k). The totals exclude 3 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. One trade stands out by size: a sale of €313k from HRT Financial LP, disclosed on 11 September 2026, or 4.8% of market capitalisation. Those buying include 2 senior executives, 1 major shareholder and 1 chief executive.
The last insider purchase was made public on 11 September 2026, 42 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4.
For context, the typical company on the same exchange (median of 3,167 companies) published 24 filings over the same period, against 54 filings here. Over the whole record (from 2023), the tally stands at 13 purchases and 11 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 3.9 m USD and net income at -12.6 m USD.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
65
Thresholds
n/a
Buy Volume
€442,380
13 ops. · all time
Sell Volume
€629,053
11 ops. · all time
Who traded when
BuySaleHRT Financial LP9 buys9 sales
Nathaniel A. Grawey1 buy
Steven M. Foster1 buy
Wyatt D. Geist1 buy
Since the insiders bought
- -55.9%Entry US$5.56 · Close 19 Oct 2026 US$2.45
- -80.0%Entry US$868.00 · Close at T+365 US$173.88
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$2.51
Analyst consensus
2 analysts1.50/5
US$10.00Target US$44.38(+1668%)US$78.75
Income statement
RevenueUS$3.9M
Gross profitUS$2.4M60% margin
EBITDA-US$12M-305% margin
Net income-US$12.6M-257.9% margin
Valuation
PER (forward)-0.2x
P/Book0.8x
Beta1.36
Balance sheet & cash
Market capUS$6.7M
Total debtUS$141k
Free Cash Flow-US$11M
Debt / Equity257%
Profitability & ownership
ROE-551.2%
ROA-72.0%
% insiders2.2%
% institutions1.7%
Last declaration on 11 September 2026
Declarations65 total
707 shares@ US$3.340.031% mcap0.2% of flowCommon StockSEC:0001475597-26-000240:0
Canonical exit: 7 Dec 2026 (T+90)
50,395 shares@ US$2.611.75% mcap11.9% of flowCommon StockSEC:0001475597-26-000240:1
9,948 shares@ US$4.270.56% mcap3.8% of flowCommon StockSEC:0001475597-26-000240:3
31,227 shares@ US$2.921.21% mcap8.2% of flowCommon StockSEC:0001475597-26-000240:4
Canonical exit: 9 Dec 2026 (T+90)
28,267 shares@ US$4.021.51% mcap10.3% of flowCommon StockSEC:0001475597-26-000240:5
Canonical exit: 9 Dec 2026 (T+90)
65,582 shares@ US$5.564.85% mcap33.0% of flowCommon StockSEC:0001475597-26-000240:7
39,508 shares@ US$3.401.79% mcap12.2% of flowCommon StockSEC:0001475597-26-000240:2
Canonical exit: 8 Dec 2026 (T+90)
8,431 shares@ US$4.920.59% mcap3.8% of flowCommon StockSEC:0001475597-26-000240:6
Canonical exit: 9 Dec 2026 (T+90)
30 shares0Common StockSEC:0001213900-26-098774:0
11 shares@ US$3.450.0005% mcap0.2% of flowCommon StockSEC:0001213900-26-098774:1
1,658 shares@ US$3.980.31% mcap0.6% of flowCommon StockSEC:0001475597-26-000234:0
Canonical exit: 2 Dec 2026 (T+90)
1,506 shares@ US$3.700.26% mcap0.5% of flowCommon StockSEC:0001475597-26-000234:1
1,790 shares@ US$4.570.38% mcap0.7% of flowCommon StockSEC:0001475597-26-000230:0
Canonical exit: 30 Nov 2026 (T+90)
450 shares@ US$4.530.096% mcap0.2% of flowCommon StockSEC:0001475597-26-000230:1
12,376 shares@ US$5.213.01% mcap5.8% of flowCommon StockSEC:0001475597-26-000226:0
Canonical exit: 26 Nov 2026 (T+90)
5,981 shares@ US$6.351.78% mcap3.4% of flowCommon StockSEC:0001475597-26-000226:1
Canonical exit: 26 Nov 2026 (T+90)
4,932 shares@ US$7.071.63% mcap3.1% of flowCommon StockSEC:0001475597-26-000226:2
2,091 shares@ US$7.900.77% mcap1.5% of flowCommon StockSEC:0001475597-26-000226:3
1,276 shares@ US$4.660.28% mcap0.5% of flowCommon StockSEC:0001475597-26-000226:4
419 shares@ US$4.960.097% mcap0.2% of flowCommon StockSEC:0001475597-26-000221:0
58,987 shares0Common StockSEC:0001213900-26-085232:0
10,732 shares0Common StockSEC:0001213900-26-085249:0
12,978 shares@ US$0.1980.12% mcap98.6% of flowCommon StockSEC:0001213900-26-085232:1
140,936 shares0Common StockSEC:0001213900-26-085230:0
64,479 shares0Common StockSEC:0001213900-26-085243:0
25 of 65 declarations
About Tenon Medical, Inc.
Tenon Medical, Inc. is a company focused on developing innovative medical solutions for the treatment of musculoskeletal disorders. It is listed on the XNAS market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
